
Benny Quoc Tieu
Supervisory Patent Examiner (ID: 2443, Phone: (571)272-7490 , Office: P/2674 )
| Most Active Art Unit | 2642 |
| Art Unit(s) | 2614, 2642, 2625, 2742, 2674, 2682 |
| Total Applications | 759 |
| Issued Applications | 578 |
| Pending Applications | 87 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15422559
[patent_doc_number] => 10544193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Compositions and methods for treating diseases by inhibiting exosome release
[patent_app_type] => utility
[patent_app_number] => 16/030430
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14917
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16030430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/030430 | Compositions and methods for treating diseases by inhibiting exosome release | Jul 8, 2018 | Issued |
Array
(
[id] => 15225227
[patent_doc_number] => 10500318
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-12-10
[patent_title] => Dosing regimens for treating hypoxia-associated tissue damage
[patent_app_type] => utility
[patent_app_number] => 16/027080
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4903
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16027080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/027080 | Dosing regimens for treating hypoxia-associated tissue damage | Jul 2, 2018 | Issued |
Array
(
[id] => 14497925
[patent_doc_number] => 20190192617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/023383
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023383 | METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS | Jun 28, 2018 | Abandoned |
Array
(
[id] => 16533310
[patent_doc_number] => 10875893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
[patent_app_type] => utility
[patent_app_number] => 16/020987
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 62074
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16020987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/020987 | Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods | Jun 26, 2018 | Issued |
Array
(
[id] => 14342205
[patent_doc_number] => 20190153075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHODS FOR RAISING ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/011158
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011158 | Methods for raising antibodies | Jun 17, 2018 | Issued |
Array
(
[id] => 16957160
[patent_doc_number] => 11061013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Single molecule proteomics
[patent_app_type] => utility
[patent_app_number] => 16/011337
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 14736
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011337 | Single molecule proteomics | Jun 17, 2018 | Issued |
Array
(
[id] => 13942381
[patent_doc_number] => 10206935
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-02-19
[patent_title] => Cream that treats pododermatitis
[patent_app_type] => utility
[patent_app_number] => 16/010133
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 852
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010133 | Cream that treats pododermatitis | Jun 14, 2018 | Issued |
Array
(
[id] => 16711899
[patent_doc_number] => 20210079046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => NON-CHROMATOGRAPHIC PURIFICATION OF MACROCYCLIC PEPTIDES BY A RESIN CATCH AND RELEASE
[patent_app_type] => utility
[patent_app_number] => 16/618847
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618847
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618847 | Non-chromatographic purification of macrocyclic peptides by a resin catch and release | Jun 7, 2018 | Issued |
Array
(
[id] => 16246100
[patent_doc_number] => 10745441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Ultra-pure agonists of guanylate cyclase C, method of making and using same
[patent_app_type] => utility
[patent_app_number] => 16/000251
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32166
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000251 | Ultra-pure agonists of guanylate cyclase C, method of making and using same | Jun 4, 2018 | Issued |
Array
(
[id] => 13440511
[patent_doc_number] => 20180271798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES
[patent_app_type] => utility
[patent_app_number] => 16/000147
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000147 | Methods and compositions for modifying mucous membranes | Jun 4, 2018 | Issued |
Array
(
[id] => 16991796
[patent_doc_number] => 20210230216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD FOR PURIFYING LONG CHAIN POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 15/733862
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 440
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733862 | Method for purifying long chain polypeptide | May 29, 2018 | Issued |
Array
(
[id] => 13778015
[patent_doc_number] => 20190002546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHODS AND COMPOSITIONS FOR BINDING VEGF
[patent_app_type] => utility
[patent_app_number] => 15/985541
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985541
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985541 | METHODS AND COMPOSITIONS FOR BINDING VEGF | May 20, 2018 | Abandoned |
Array
(
[id] => 13960085
[patent_doc_number] => 20190056386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 15/985334
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985334 | ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION | May 20, 2018 | Abandoned |
Array
(
[id] => 15697161
[patent_doc_number] => 10604749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Factor IX variants with clotting activity in absence of their cofactor and/or with increased F.IX clotting activity and their use for treating bleeding disorders
[patent_app_type] => utility
[patent_app_number] => 15/981177
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 49
[patent_no_of_words] => 12080
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981177
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981177 | Factor IX variants with clotting activity in absence of their cofactor and/or with increased F.IX clotting activity and their use for treating bleeding disorders | May 15, 2018 | Issued |
Array
(
[id] => 16156547
[patent_doc_number] => 20200216506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => NUCLEIC ACIDS THAT MANIPULATE IMMUNE PATHWAYS
[patent_app_type] => utility
[patent_app_number] => 16/612713
[patent_app_country] => US
[patent_app_date] => 2018-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612713 | NUCLEIC ACIDS THAT MANIPULATE IMMUNE PATHWAYS | May 11, 2018 | Abandoned |
Array
(
[id] => 16484321
[patent_doc_number] => 20200377922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHOD FOR MODIFYING MICROCYSTINS AND NODULARINS
[patent_app_type] => utility
[patent_app_number] => 16/605248
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605248 | Method for modifying microcystins and nodularins | May 8, 2018 | Issued |
Array
(
[id] => 16893213
[patent_doc_number] => 11034746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Double-acylated GLP-1 derivatives
[patent_app_type] => utility
[patent_app_number] => 15/968950
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37895
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15968950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/968950 | Double-acylated GLP-1 derivatives | May 1, 2018 | Issued |
Array
(
[id] => 14099091
[patent_doc_number] => 20190091221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 15/959482
[patent_app_country] => US
[patent_app_date] => 2018-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15959482
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/959482 | Methods and compositions for treating viral or virally-induced conditions | Apr 22, 2018 | Issued |
Array
(
[id] => 15035633
[patent_doc_number] => 20190328821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => METHODS FOR REDUCING OXIDATIVE DAMAGE
[patent_app_type] => utility
[patent_app_number] => 15/956941
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956941 | METHODS FOR REDUCING OXIDATIVE DAMAGE | Apr 18, 2018 | Abandoned |
Array
(
[id] => 13733935
[patent_doc_number] => 20180371435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/955640
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955640
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955640 | SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF | Apr 16, 2018 | Abandoned |